Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive Aspergillosis
Changing antifungals was associated with longer hospital stays and costs and higher all-cause costs over 12-months.
Authors
- Barbara D. Alexander (ORCID: https://orcid.org/0000-0001-5868-0529)
- Mitch DeKoven (ORCID: https://orcid.org/0000-0001-9346-6202)
- Melissa D. Johnson (ORCID: https://orcid.org/0000-0002-6606-9460)
- Vamshi Ruthwik Anupindi (ORCID: https://orcid.org/0000-0002-0385-8657)
- Belinda Lovelace (ORCID: https://orcid.org/0000-0002-9986-2326)
- Lia Pizzicato (ORCID: https://orcid.org/0000-0002-3889-7138)
- Mark Bresnik (ORCID: https://orcid.org/0000-0002-1787-9010)
- Craig I Coleman (ORCID: https://orcid.org/0000-0003-4868-7158)
Institutions
- University of Connecticut (US)
- Duke University (US)
- Princeton University (US)
- IQVIA (United States) (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1093/ofid/ofae747
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.39